House Ways and Means Committee leaders today released a white paper summarizing stakeholder recommendations for Medicare-related legislation to address the opioid crisis, which the committee plans to use to develop and advance bipartisan policies. The committee in February requested feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. “We are hopeful this legislation will touch on many of the stakeholder recommendations, including but not limited to those related to Medicare treatment options/coverage, improving data tracking/prescribing practices, and educating providers and beneficiaries about the risks of long-term opioid use,” the white paper states. AHA submitted its policy recommendations to the committee last month.

Related News Articles

Headline
The Centers for Medicare…
Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
The AHA today responded to a RAND Corporation study that found that certain prices paid to hospitals by private health plans are high relative to Medicare and…
Headline
A federal district court judge yesterday ruled that the Department of Health and Human Services would get "first crack at crafting appropriate remedial…
Headline
Laws that allow pharmacists to dispense the opioid antidote naloxone without a physician’s prescription are associated with a sharp reduction in fatal opioid-…
Headline
The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid…